-
Marketing Group Petitions FDA To Change Drug Advertising Rules
Warnings About Specific Side Effects Would Be Eliminated, And Replaced By Boilerplate Language On March 31, 2006 the Coalition for Healthcare Communication — a group of drug advertising agencies and public relations companies —…
-
First N.J. Vioxx Trial Involving Long-term Use Draws To An End
Will Jury Verdict Be For Plaintiffs Cona And McDarby, or Defendant Merck? The first two Vioxx cases in New Jersey involving long-term Vioxx use, Cona v. Merck and McDarby v. Merck, may have a…
-
Whistleblower David Graham Discusses Problems With The FDA
In-depth Interview Of This Top FDA Insider From 2005, In Seven Parts In August and September 2005 Dr. Joseph Mercola — an osteopathic physician, also known as a DO — published on his web…
-
California Vioxx Cases: First Vioxx Trial To Start In June 2006
Will Judge Chaney Schedule A Single Plaintiff Case Or Multiple Plaintiffs Case? The first Vioxx trial in California is scheduled to start on June 21, 2006, but it is still unknown whether the jury…
-
Ortho Evra MDL Cases Assigned to Federal Court Judge Katz in Ohio
Lawsuits Allege Birth Control Patch Causes Harmful Blood Clots On March 1, 2006 U.S. District Judge David A. Katz, of the Northern District of Ohio, was selected to oversee the federal court Ortho Evra…
-
Concern Expressed About Heart Risks From Adderall, Ritalin, Other ADHD Drugs
Early Release of Dr. Nissen’s NEJM Article: "ADHD Drugs and Cardiovascular Risks" Cardiologist Steven E. Nissen believes that Shire Plc’s Adderall, Novartis AG’s Ritalin, and other drugs used to treat attention deficit-hyperactivity disorder (ADHD)…